vs
EXACT SCIENCES CORP（EXAS）与六旗（FUN）财务数据对比。点击上方公司名可切换其他公司
EXACT SCIENCES CORP的季度营收约是六旗的1.4倍（$878.4M vs $650.1M），EXACT SCIENCES CORP净利率更高（-9.8% vs -14.2%，领先4.4%），EXACT SCIENCES CORP自由现金流更多（$120.4M vs $-109.3M）
Exact Sciences是总部位于美国威斯康星州麦迪逊的分子诊断企业，专注于早期癌症检测领域。公司核心产品覆盖结直肠癌筛查与预防场景，其中Cologuard是全球首个获批的结直肠癌粪便DNA检测产品，同时还提供其他多种癌症的筛查服务及精准肿瘤检测解决方案。
六旗娱乐是总部位于美国北卡罗来纳州夏洛特的游乐园运营企业，由雪松会与原六旗公司于2024年7月1日对等合并而成，是全球最大的区域性游乐园运营商。旗下共运营42个场地，包含27座游乐园、15座水上乐园，配套9处 onsite 度假物业。
EXAS vs FUN — 直观对比
营收规模更大
EXAS
是对方的1.4倍
$650.1M
净利率更高
EXAS
高出4.4%
-14.2%
自由现金流更多
EXAS
多$229.7M
$-109.3M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $878.4M | $650.1M |
| 净利润 | $-86.0M | $-92.4M |
| 毛利率 | 70.1% | 91.4% |
| 营业利润率 | -9.4% | -3.8% |
| 净利率 | -9.8% | -14.2% |
| 营收同比 | 23.1% | — |
| 净利润同比 | 90.1% | — |
| 每股收益（稀释后） | $-0.45 | $-0.93 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EXASFUN
| Q4 25 | $878.4M | $650.1M | ||
| Q3 25 | $850.7M | $1.3B | ||
| Q2 25 | $811.1M | $930.4M | ||
| Q1 25 | $706.8M | $202.1M | ||
| Q4 24 | $713.4M | — | ||
| Q3 24 | $708.7M | $1.3B | ||
| Q2 24 | $699.3M | $571.6M | ||
| Q1 24 | $637.5M | — |
净利润EXASFUN
| Q4 25 | $-86.0M | $-92.4M | ||
| Q3 25 | $-19.6M | $-1.2B | ||
| Q2 25 | $-1.2M | $-99.6M | ||
| Q1 25 | $-101.2M | $-219.7M | ||
| Q4 24 | $-864.6M | — | ||
| Q3 24 | $-38.2M | $111.0M | ||
| Q2 24 | $-15.8M | $55.6M | ||
| Q1 24 | $-110.2M | — |
毛利率EXASFUN
| Q4 25 | 70.1% | 91.4% | ||
| Q3 25 | 68.6% | 91.6% | ||
| Q2 25 | 69.3% | 91.3% | ||
| Q1 25 | 70.8% | 89.3% | ||
| Q4 24 | 69.0% | — | ||
| Q3 24 | 69.4% | 91.9% | ||
| Q2 24 | 69.8% | 90.7% | ||
| Q1 24 | 70.0% | — |
营业利润率EXASFUN
| Q4 25 | -9.4% | -3.8% | ||
| Q3 25 | -3.0% | -83.7% | ||
| Q2 25 | -0.3% | 8.0% | ||
| Q1 25 | -13.6% | -158.9% | ||
| Q4 24 | -122.8% | — | ||
| Q3 24 | -5.6% | 19.5% | ||
| Q2 24 | -3.8% | 21.6% | ||
| Q1 24 | -16.7% | — |
净利率EXASFUN
| Q4 25 | -9.8% | -14.2% | ||
| Q3 25 | -2.3% | -90.1% | ||
| Q2 25 | -0.1% | -10.7% | ||
| Q1 25 | -14.3% | -108.7% | ||
| Q4 24 | -121.2% | — | ||
| Q3 24 | -5.4% | 8.2% | ||
| Q2 24 | -2.3% | 9.7% | ||
| Q1 24 | -17.3% | — |
每股收益（稀释后）EXASFUN
| Q4 25 | $-0.45 | $-0.93 | ||
| Q3 25 | $-0.10 | $-11.77 | ||
| Q2 25 | $-0.01 | $-0.99 | ||
| Q1 25 | $-0.54 | $-2.20 | ||
| Q4 24 | $-4.69 | — | ||
| Q3 24 | $-0.21 | $1.10 | ||
| Q2 24 | $-0.09 | — | ||
| Q1 24 | $-0.60 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $964.7M | $91.1M |
| 总债务越低越好 | — | $5.2B |
| 股东权益账面价值 | $2.4B | $549.8M |
| 总资产 | $5.9B | $7.8B |
| 负债/权益比越低杠杆越低 | — | 9.40× |
8季度趋势，按日历期对齐
现金及短期投资EXASFUN
| Q4 25 | $964.7M | $91.1M | ||
| Q3 25 | $1.0B | $70.7M | ||
| Q2 25 | $858.4M | $107.4M | ||
| Q1 25 | $786.2M | $61.5M | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.0B | $89.7M | ||
| Q2 24 | $946.8M | $52.9M | ||
| Q1 24 | $652.1M | — |
总债务EXASFUN
| Q4 25 | — | $5.2B | ||
| Q3 25 | — | $5.0B | ||
| Q2 25 | — | $5.3B | ||
| Q1 25 | — | $5.0B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $4.6B | ||
| Q2 24 | — | $2.3B | ||
| Q1 24 | — | — |
股东权益EXASFUN
| Q4 25 | $2.4B | $549.8M | ||
| Q3 25 | $2.5B | $614.3M | ||
| Q2 25 | $2.5B | $1.8B | ||
| Q1 25 | $2.4B | $1.8B | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $3.2B | $2.3B | ||
| Q2 24 | $3.2B | — | ||
| Q1 24 | $3.1B | — |
总资产EXASFUN
| Q4 25 | $5.9B | $7.8B | ||
| Q3 25 | $5.9B | $7.9B | ||
| Q2 25 | $5.8B | $9.5B | ||
| Q1 25 | $5.7B | $9.2B | ||
| Q4 24 | $5.9B | — | ||
| Q3 24 | $6.7B | $9.4B | ||
| Q2 24 | $6.7B | $2.3B | ||
| Q1 24 | $6.4B | — |
负债/权益比EXASFUN
| Q4 25 | — | 9.40× | ||
| Q3 25 | — | 8.16× | ||
| Q2 25 | — | 2.97× | ||
| Q1 25 | — | 2.75× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.95× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $151.7M | $-37.7M |
| 自由现金流经营现金流 - 资本支出 | $120.4M | $-109.3M |
| 自由现金流率自由现金流/营收 | 13.7% | -16.8% |
| 资本支出强度资本支出/营收 | 3.6% | 11.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $356.8M | $-152.2M |
8季度趋势，按日历期对齐
经营现金流EXASFUN
| Q4 25 | $151.7M | $-37.7M | ||
| Q3 25 | $219.9M | $356.2M | ||
| Q2 25 | $89.0M | $187.0M | ||
| Q1 25 | $30.8M | $-178.0M | ||
| Q4 24 | $47.1M | — | ||
| Q3 24 | $138.7M | $337.4M | ||
| Q2 24 | $107.1M | — | ||
| Q1 24 | $-82.3M | — |
自由现金流EXASFUN
| Q4 25 | $120.4M | $-109.3M | ||
| Q3 25 | $190.0M | $256.2M | ||
| Q2 25 | $46.7M | $18.8M | ||
| Q1 25 | $-365.0K | $-318.0M | ||
| Q4 24 | $10.7M | — | ||
| Q3 24 | $112.6M | $227.7M | ||
| Q2 24 | $71.2M | — | ||
| Q1 24 | $-120.0M | — |
自由现金流率EXASFUN
| Q4 25 | 13.7% | -16.8% | ||
| Q3 25 | 22.3% | 19.4% | ||
| Q2 25 | 5.8% | 2.0% | ||
| Q1 25 | -0.1% | -157.4% | ||
| Q4 24 | 1.5% | — | ||
| Q3 24 | 15.9% | 16.9% | ||
| Q2 24 | 10.2% | — | ||
| Q1 24 | -18.8% | — |
资本支出强度EXASFUN
| Q4 25 | 3.6% | 11.0% | ||
| Q3 25 | 3.5% | 7.6% | ||
| Q2 25 | 5.2% | 18.1% | ||
| Q1 25 | 4.4% | 69.3% | ||
| Q4 24 | 5.1% | — | ||
| Q3 24 | 3.7% | 8.1% | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 5.9% | — |
现金转化率EXASFUN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.04× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXAS
| Screening | $695.1M | 79% |
| Precision Oncology | $183.2M | 21% |
FUN
| Admission | $327.4M | 50% |
| Food Merchandiseand Gaming | $205.7M | 32% |
| Accommodations Extra Charge Products And Other | $117.0M | 18% |
